PRINCIPAL FINANCIAL GROUP INC
Position in VKTX — Viking Therapeutics, Inc.
CIK 1126328
DES MOINES, IA
Position in VKTX
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$17,099,248
-$973,808 QoQ
Shares Held
525,484
+2.3% QoQ
Ownership
0.453%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VKTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRINCIPAL FINANCIAL GROUP INC holds $1,683,587,850 across 95 Biotechnology names. VKTX ranks #29 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
896,397 | $205,032,885 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
426,523 | $190,459,579 | |
| 3 | INSM |
INSMED Inc
|
916,464 | $149,860,192 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
1,330,415 | $98,796,617 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
120,425 | $93,045,171 | |
| 6 | GPCR |
Structure Therapeutics Inc.
|
1,753,764 | $84,531,424 | |
| 7 | CYTK |
Cytokinetics Inc
|
1,093,485 | $72,071,595 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
350,488 | $59,239,481 |
All Filings in VKTX
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $17,099,248 | 525,484 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $18,073,056 | 513,731 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $13,507,972 | 514,002 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $14,974,248 | 565,066 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $14,444,959 | 598,135 | Shares | Defined | 2025-04-28 | |
| 2024-12-31 | $25,301,463 | 628,764 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $37,576,256 | 593,528 | Shares | Defined | 2024-10-31 | |
| 2024-06-30 | $24,214,913 | 456,799 | Shares | Defined | 2024-07-29 | |
| 2024-03-31 | $29,588,798 | 360,839 | Shares | Defined | 2024-04-29 | |
| 2023-12-31 | $206,831 | 11,114 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $112,283 | 10,143 | Shares | Defined | 2023-11-02 | |
| 2023-06-30 | $183,999 | 11,351 | Shares | Defined | 2023-08-07 | |
| 2021-09-30 | $92,485 | 14,727 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $102,512 | 17,114 | Shares | Defined | 2021-08-10 | |
| 2020-12-31 | $84,624 | 15,031 | Shares | Defined | 2021-02-23 | |
| 2020-09-30 | $85,565 | 14,702 | Shares | Defined | 2020-11-06 | |
| 2020-06-30 | $111,250 | 15,430 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $49,331 | 10,541 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||